Patent applications and USPTO patent grants for Astellas Pharma Inc..The latest application filed is for "genetically engineered oncolytic vaccinia viruses and methods of uses thereof".
Patent | Date |
---|---|
Genetically Engineered Oncolytic Vaccinia Viruses And Methods Of Uses Thereof App 20220290179 - Nakao; Shinsuke ;   et al. | 2022-09-15 |
Guide Rna For Editing Target, With Functional Nucleotide Sequence Added App 20220275359 - YOSHIMI; Eiji ;   et al. | 2022-09-01 |
Granular Pharmaceutical Composition App 20220257696 - Nishiura; Mare ;   et al. | 2022-08-18 |
Cell penetrating peptide Grant 11,414,456 - Endo , et al. August 16, 2 | 2022-08-16 |
Method For Treating Muscular Dystrophy By Targeting Dmpk Gene App 20220233721 - YOSHIMI; Eiji ;   et al. | 2022-07-28 |
Therapy involving antibodies against Claudin 18.2 for treatment of cancer Grant 11,395,852 - Sahin , et al. July 26, 2 | 2022-07-26 |
Transcriptional regulatory fusion polypeptide Grant 11,390,652 - Endo , et al. July 19, 2 | 2022-07-19 |
Pharmaceutical composition Grant 11,376,328 - Yoshida , et al. July 5, 2 | 2022-07-05 |
2-acylaminothiazole derivative or salt thereof Grant RE49,111 - Takahashi , et al. June 21, 2 | 2022-06-21 |
Nanoparticle, Contrast Agent For Magnetic Resonance Imaging Comprising Same And Zwitterionic Ligand Compound App 20220184236 - Mizutani; Tsuyoshi ;   et al. | 2022-06-16 |
Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of Cancer App 20220184209 - Sahin; Ugur ;   et al. | 2022-06-16 |
Exercise Management System, Server System, Terminal Device, And Exercise Management Method App 20220168614 - KANAYAMA; Motohiro | 2022-06-02 |
Genetically engineered vaccinia viruses Grant 11,344,589 - Nakamura , et al. May 31, 2 | 2022-05-31 |
Antibodies Useful In Cancer Diagnosis App 20220162302 - MITNACHT-KRAUS; Rita ;   et al. | 2022-05-26 |
Pharmaceutical Composition App 20220152020 - SASAKI; Akihiko ;   et al. | 2022-05-19 |
Exercise Management System, Server System, Terminal Device, And Exercise Management Method App 20220143464 - NISHIMOTO; Yasuhiro ;   et al. | 2022-05-12 |
Thrombin-carrying Hemostatic Sheet App 20220143263 - OGINO; Makoto ;   et al. | 2022-05-12 |
Nucleic acid for treating mite allergy Grant 11,312,966 - Marui , et al. April 26, 2 | 2022-04-26 |
Conjugate Comprising Ligand, Spacer, Peptide Linker, And Biomolecule App 20220105194 - Akaiwa; Michinori ;   et al. | 2022-04-07 |
Conjugate Comprising Ligand And Ceacam5 Antibody Fab Fragment App 20220096653 - Akaiwa; Michinori ;   et al. | 2022-03-31 |
Cell culturing method using nucleic acid-containing medium Grant 11,286,459 - Takagi , et al. March 29, 2 | 2022-03-29 |
Method For Producing Nanoparticle Having Metal Particle Which Contains Iron Oxide To Which One Or More Hydrophilic Ligands Are Coordination Bonded App 20220089455 - KIKUCHI; Takashi ;   et al. | 2022-03-24 |
Antibodies useful in cancer diagnosis Grant 11,279,757 - Mitnacht-Kraus , et al. March 22, 2 | 2022-03-22 |
Anti-human NGF antibody Fab fragment and methods for treating postoperative pain related to NGF Grant 11,260,124 - Tanaka , et al. March 1, 2 | 2022-03-01 |
Pharmaceutical Composition Comprising Anti-human Tslp Receptor Antibody App 20220023422 - IKEDA; Megumi ;   et al. | 2022-01-27 |
METHOD FOR TREATING CANCER USING ARTIFICIAL ADJUVANT CELL (aAVC) App 20220016239 - OHSUMI; Keisuke ;   et al. | 2022-01-20 |
Method for producing renal progenitor cells Grant 11,225,642 - Osafune , et al. January 18, 2 | 2022-01-18 |
Granular Pharmaceutical Composition App 20220008501 - Nishiura; Mare ;   et al. | 2022-01-13 |
ANTI-HUMAN Fn14 ANTIBODY App 20210388096 - ITO; Misato ;   et al. | 2021-12-16 |
Combination for Treating Cancer App 20210386826 - Boshoff; Christoffel Hendrik ;   et al. | 2021-12-16 |
Anti-human CD73 antibody Grant 11,180,554 - Sato , et al. November 23, 2 | 2021-11-23 |
Pharmaceutical Composition Containing Tagged Site-antihuman Antibody Fab Fragment Complex App 20210355233 - Suemitsu; Jumpei ;   et al. | 2021-11-18 |
Method For Treating Muscular Dystrophy By Targeting Utrophin Gene App 20210355464 - YOSHIMI; Eiji ;   et al. | 2021-11-18 |
Pharmaceutical Composition For Oral Administration App 20210346392 - KOJIMA; Ryo ;   et al. | 2021-11-11 |
Nucleic Acid For Treating Mite Allergy App 20210340549 - MARUI; Takanori ;   et al. | 2021-11-04 |
Fatty Acid Derivative Labeled With Positron-emitting Radionuclide App 20210338845 - Murakami; Yoshihiro ;   et al. | 2021-11-04 |
Complex Having Anti-human Muc1 Antibody Fab Fragment, Peptide Linker And/or Ligand App 20210340276 - ASANO; Toru ;   et al. | 2021-11-04 |
Methods And Compositions For Prediction Of Therapeutic Efficacy Of Cancer Treatments And Cancer Prognosis App 20210324472 - Sahin; Ugur ;   et al. | 2021-10-21 |
Pharmaceutical Composition For Modified Release App 20210322387 - TAKAISHI; YUUKI ;   et al. | 2021-10-21 |
Cancer Therapy By Combination Use Of Oncolytic Vaccinia Virus And Immune Checkpoint Inhibitor, And Pharmaceutical Composition And Combination Medicine For Use In The Cancer Therapy App 20210315951 - NAKAO; Shinsuke ;   et al. | 2021-10-14 |
Pharmaceutical Composition Comprising Diamino Heterocyclic Carboxamide Compound As Active Ingredient App 20210290618 - EGUCHI; Tomohiro ;   et al. | 2021-09-23 |
Detection Of Cldn18-arhgap6 Fusion Gene Or Cldn18-arhgap26 Fusion Gene In Pancreatic Cancer App 20210292853 - SASAKI; Hiroki | 2021-09-23 |
Anti-human Ig.beta. antibody Grant 11,059,889 - Yamajuku , et al. July 13, 2 | 2021-07-13 |
Detection of CLDN18-ARHGAP6 fusion gene or CLDN18-ARHGAP26 fusion gene in pancreatic cancer Grant 11,053,553 - Sasaki July 6, 2 | 2021-07-06 |
Anti-human BDCA-2 antibody Grant 11,046,770 - Nakao , et al. June 29, 2 | 2021-06-29 |
Pharmaceutical composition comprising diamino heterocyclic carboxamide compound as active ingredient Grant 11,045,468 - Eguchi , et al. June 29, 2 | 2021-06-29 |
Granular Pharmaceutical Composition App 20210161996 - Nishiura; Mare ;   et al. | 2021-06-03 |
Nucleic Acid For Treating Mite Allergy App 20210163957 - MARUI; Takanori ;   et al. | 2021-06-03 |
Cell Penetrating Peptide App 20210163533 - Endo; Hideki ;   et al. | 2021-06-03 |
Nucleic Acid For Treating Crustacean Allergy App 20210163549 - MARUI; Takanori | 2021-06-03 |
Genetic Products Differentially Expressed In Tumors And The Use Thereof App 20210145700 - Tureci; Ozlem ;   et al. | 2021-05-20 |
Pharmaceutical Composition For Suppressing Atrial Fibrillation Having As Active Ingredient Anti-human Ngf Antibody Or Antigen-binding Fragment Thereof App 20210147529 - SHAKUSHIRO; Kohsuke ;   et al. | 2021-05-20 |
Pharmaceutical composition comprising anti-human TSLP receptor antibody Grant 10,994,011 - Ikeda , et al. May 4, 2 | 2021-05-04 |
Medicine For Preventing Or Treating Ophthalmic Disease Associated With Enhanced Intraocular Neovascularization And/or Intraocular Vascular Permeability App 20210113529 - HARA; Hideaki ;   et al. | 2021-04-22 |
Pyridine derivative Grant 10,975,091 - Kawaguchi , et al. April 13, 2 | 2021-04-13 |
Salt And Crystal Of Triazolopyrazine Derivative App 20210094955 - KOJIMA; Haruka ;   et al. | 2021-04-01 |
Pharmaceutical Composition For Modified Release App 20210085654 - TAKAISHI; YUUKI ;   et al. | 2021-03-25 |
Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic cancer Grant 10,946,069 - Sahin , et al. March 16, 2 | 2021-03-16 |
Combination Therapy App 20210069166 - Gibbons; Jacqueline ;   et al. | 2021-03-11 |
Methods and compositions for prediction of therapeutic efficacy of cancer treatments and cancer prognosis Grant 10,927,413 - Sahin , et al. February 23, 2 | 2021-02-23 |
Bispecific antibody format Grant 10,927,185 - Ito , et al. February 23, 2 | 2021-02-23 |
Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of Cancer App 20210023177 - Sahin; Ugur ;   et al. | 2021-01-28 |
Genetically engineered vaccinia viruses Grant 10,888,594 - Nakao , et al. January 12, 2 | 2021-01-12 |
Method For Producing Renal Progenitor Cells App 20200407692 - Kawamoto; Tatsuya ;   et al. | 2020-12-31 |
Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of Cancer App 20200390887 - Sahin; Ugur ;   et al. | 2020-12-17 |
Stable Pharmaceutical Composition For Oral Administration App 20200383977 - MIYAZAKI; Masakazu ;   et al. | 2020-12-10 |
Method For Detecting Ocln-arhgap26 Gene App 20200385779 - Sasaki; Hiroki ;   et al. | 2020-12-10 |
Monoclonal Antibodies Against Claudin-18 For Treatment Of Cancer App 20200385448 - Sahin; Ugur ;   et al. | 2020-12-10 |
Genetically engineered vaccinia viruses Grant 10,849,946 - Nakao , et al. December 1, 2 | 2020-12-01 |
Pharmaceutical composition for modified release Grant 10,842,780 - Takaishi , et al. November 24, 2 | 2020-11-24 |
Combination Therapy For The Treatment Of Acute Myeloid Leukemia App 20200360372 - BAHCECI; Erkut ;   et al. | 2020-11-19 |
Novel Genetically Engineered Vaccinia Viruses App 20200338149 - NAKAO; Shinsuke ;   et al. | 2020-10-29 |
Combination therapy involving antibodies against Claudin 18.2 for treatment of cancer Grant 10,813,996 - Sahin , et al. October 27, 2 | 2020-10-27 |
Stable pharmaceutical composition for oral administration Grant 10,786,500 - Miyazaki , et al. September 29, 2 | 2020-09-29 |
Pharmaceutical Composition Comprising Pegylated Fab' Fragment Of Anti-human Ngf Antibody App 20200299371 - YAMAMOTO; Ayano ;   et al. | 2020-09-24 |
Method For Detecting Rp2-arhgap6 Gene App 20200299782 - Sasaki; Hiroki ;   et al. | 2020-09-24 |
Genetically Engineered Vaccinia Viruses App 20200289592 - Nakamura; Takafumi ;   et al. | 2020-09-17 |
Pharmaceutical Composition For Cancer Immunotherapy And/or Immunological Activation Containing Diamino Heterocyclic Carboxamide Compound As Active Ingredient App 20200289505 - Eguchi; Tomohiro ;   et al. | 2020-09-17 |
Quinazoline compound Grant 10,774,082 - Kuramoto , et al. Sept | 2020-09-15 |
Tetrahydroisoquinoline Derivatives App 20200270266 - SATO; Ippei ;   et al. | 2020-08-27 |
Novel Anti-human Muc1 Antibody Fab Fragment App 20200261603 - MORINAKA; Akifumi ;   et al. | 2020-08-20 |
Pharmaceutical composition for cancer immunotherapy and/or immunological activation containing diamino heterocyclic carboxamide compound as active ingredient Grant 10,744,134 - Eguchi , et al. A | 2020-08-18 |
Monoclonal antibodies against claudin-18 for treatment of cancer Grant 10,738,108 - Sahin , et al. A | 2020-08-11 |
Method for producing renal progenitor cells Grant 10,731,133 - Kawamoto , et al. | 2020-08-04 |
Piperazine derivative Grant 10,710,988 - Sugane , et al. | 2020-07-14 |
Granular Pharmaceutical Composition App 20200206305 - Nishiura; Mare ;   et al. | 2020-07-02 |
Antibodies Useful In Cancer Diagnosis App 20200199221A1 - | 2020-06-25 |
Tetrahydroisoquinoline derivatives Grant 10,689,393 - Sato , et al. | 2020-06-23 |
Novel Anti-human Muc1 Antibody Fab Fragment App 20200171174 - MORINAKA; Akifumi ;   et al. | 2020-06-04 |
Pharmaceutical Composition for Oral Administration Comprising Enzalutamide App 20200146977 - Umemoto; Yoshiaki ;   et al. | 2020-05-14 |
Quinazoline Compound App 20200140437 - Kuramoto; Kazuyuki ;   et al. | 2020-05-07 |
Pharmaceutical Composition App 20200138957 - Yoshida; Takatsune ;   et al. | 2020-05-07 |
Novel Anti-human Ceacam5 Antibody Fab Fragment App 20200123270 - Doihara; Hitoshi ;   et al. | 2020-04-23 |
Method for detecting OCLN-ARHGAP26 gene Grant 10,619,184 - Sasaki , et al. | 2020-04-14 |
Method for detecting RP2-ARHGAP6 gene Grant 10,619,216 - Sasaki , et al. | 2020-04-14 |
Diagnosis and therapy of cancer involving cancer stem cells Grant 10,604,568 - Sahin , et al. | 2020-03-31 |
Monoclonal anti-GT 468 antibodies for treatment of cancer Grant 10,596,256 - Sahin , et al. | 2020-03-24 |
Pharmaceutical composition for oral administration Grant 10,583,087 - Suda , et al. | 2020-03-10 |
Anti-human Cd73 Antibody App 20200071404 - SATO; Masahito ;   et al. | 2020-03-05 |
Formulations Of Enzalutamide App 20200060976 - Lorenz; Douglas Alan ;   et al. | 2020-02-27 |
Pyridine Derivative App 20200055868 - KAWAGUCHI; Kenichi ;   et al. | 2020-02-20 |
Quinazoline compound Grant 10,556,906 - Kuramoto , et al. Feb | 2020-02-11 |
Pharmaceutical composition for oral administration Grant 10548845 - | 2020-02-04 |
Phenyldifluoromethyl-substituted prolinamide compound Grant 10,532,979 - Nakajima , et al. Ja | 2020-01-14 |
Anti-human MUC1 antibody Fab fragment Grant 10,517,966 - Morinaka , et al. Dec | 2019-12-31 |
Novel Compound, And Method For Producing Regulatory T Cells App 20190382403 - SAKAGUCHI; Shimon ;   et al. | 2019-12-19 |
Anti-human MUC1 antibody fab fragment Grant 10,507,251 - Morinaka , et al. Dec | 2019-12-17 |
Genetically Engineered Vaccinia Viruses App 20190336552 - Nakamura; Takafumi ;   et al. | 2019-11-07 |
Transcriptional Regulatory Fusion Polypeptide App 20190330280 - ENDO; Hideki ;   et al. | 2019-10-31 |
Bispecific Trivalent Antibodies Binding To Claudin6 Or Claudin18.2 And Cd3 For Treatment Of Claudin Expressing Cancer Diseases App 20190309067 - Sahin; Ugur ;   et al. | 2019-10-10 |
NOVEL ANTI-HUMAN Ig ANTIBODY App 20190309063 - YAMAJUKU; Daisuke ;   et al. | 2019-10-10 |
Novel Anti-human Muc1 Antibody Fab Fragment App 20190307906 - MORINAKA; Akifumi ;   et al. | 2019-10-10 |
Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of Cancer App 20190298803 - Sahin; Ugur ;   et al. | 2019-10-03 |
Imidazodiazepine compound Grant 10,426,784 - Kawakami , et al. October 1, 2 | 2019-10-01 |
Quinazoline Compound App 20190292182 - Kuramoto; Kazuyuki ;   et al. | 2019-09-26 |
Pyridine derivative Grant 10,421,762 - Kawaguchi , et al. Sept | 2019-09-24 |
Stable Pharmaceutical Composition App 20190282569 - SAKURAI; Atsushi ;   et al. | 2019-09-19 |
Novel Anti-human Muc1 Antibody Fab Fragment App 20190269804 - Morinaka; Akifumi ;   et al. | 2019-09-05 |
Phenyldifluoromethyl-substituted Prolinamide Compound App 20190248738 - Nakajima; Yutaka ;   et al. | 2019-08-15 |
Novel Anti-human Bdca-2 Antibody App 20190248904 - NAKAO; Shinsuke ;   et al. | 2019-08-15 |
Fast-eluting Three-dimensionally Molded Object, Filament For Fast-eluting Three-dimensionally Molded Object, And Material For Fa App 20190217531 - IKEDA; SORATO ;   et al. | 2019-07-18 |
Detection Of Cldn18-arhgap6 Fusion Gene Or Cldn18-arhgap26 Fusion Gene In Pancreatic Cancer App 20190218620 - SASAKI; Hiroki | 2019-07-18 |
Formulations Of Enzalutamide App 20190209476 - Lorenz; Douglas Alan ;   et al. | 2019-07-11 |
Piperazine Derivative App 20190202815 - SUGANE; Takashi ;   et al. | 2019-07-04 |
Tetrahydroisoquinoline Derivatives App 20190194220 - Sato; Ippei ;   et al. | 2019-06-27 |
Phenyldifluoromethyl-substituted prolinamide compound Grant 10,322,997 - Nakajima , et al. | 2019-06-18 |
Anti-human Ig.beta. antibody Grant 10,316,086 - Yamajuku , et al. | 2019-06-11 |
Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic cancer Grant 10,314,890 - Sahin , et al. | 2019-06-11 |
Piperazine derivative Grant 10,301,286 - Sugane , et al. | 2019-05-28 |
Anti-human BDCA-2 antibody Grant 10,294,301 - Nakao , et al. | 2019-05-21 |
Combination Therapy For The Treatment Of Acute Myeloid Leukemia App 20190117649 - BAHCECI; Erkut ;   et al. | 2019-04-25 |
Pharmaceutical Composition Comprising Anti-human Tslp Receptor Antibody App 20190111129 - IKEDA; Megumi ;   et al. | 2019-04-18 |
Tetrahydroisoquinoline derivatives Grant 10,259,821 - Sato , et al. | 2019-04-16 |
Bispecific antibody binding to human TLR2 and human TLR4 Grant 10,253,105 - Takeuchi , et al. | 2019-04-09 |
Tablet App 20190076365 - HATTORI; SHOTA ;   et al. | 2019-03-14 |
Phenyldifluoromethyl-substituted Prolinamide Compound App 20190071398 - NAKAJIMA; Yutaka ;   et al. | 2019-03-07 |
Granular Pharmaceutical Composition App 20190060395 - Nishiura; Mare ;   et al. | 2019-02-28 |
Stabilized pharmaceutical composition Grant 10,188,737 - Tasaki , et al. Ja | 2019-01-29 |
Pyridine Derivative App 20180327418 - KAWAGUCHI; Kenichi ;   et al. | 2018-11-15 |
Pharmaceutical Composition For Cancer Immunotherapy And/or Immunological Activation Containing Diamino Heterocyclic Carboxamide Compound As Active Ingredient App 20180318295 - EGUCHI; Tomohiro ;   et al. | 2018-11-08 |
Production method of enzalutamide crystal form Grant 10,118,899 - Suzuki , et al. November 6, 2 | 2018-11-06 |
Amide compound Grant 10,106,523 - Okuda , et al. October 23, 2 | 2018-10-23 |
Method For Producing Renal Progenitor Cells App 20180273905 - KAWAMOTO; Tatsuya ;   et al. | 2018-09-27 |
Method For Detecting RP3-ARHGAP6 Gene App 20180251850 - Sasaki; Hiroki ;   et al. | 2018-09-06 |
Pharmaceutical composition containing mirabegron Grant 10,058,536 - Takae , et al. August 28, 2 | 2018-08-28 |
Pyridine derivative Grant 10,059,720 - Kawaguchi , et al. August 28, 2 | 2018-08-28 |
Treatment of Cancer with Enzalutamide and a CYP3A4 Inhibitor App 20180235935 - GIBBONS; Jacqueline ;   et al. | 2018-08-23 |
Method For Detecting OCLN-ARHGAP26 Gene App 20180237862 - Sasaki; Hiroki ;   et al. | 2018-08-23 |
Combination Therapy with Apalutamide App 20180228790 - GIBBONS; Jacqueline ;   et al. | 2018-08-16 |
Piperazine Derivative App 20180230131 - SUGANE; Takashi ;   et al. | 2018-08-16 |
Bicyclic pyridine compound Grant 10,023,583 - Kawaguchi , et al. July 17, 2 | 2018-07-17 |
Imidazodiazepine Compound App 20180185383 - KAWAKAMI; Shimpei ;   et al. | 2018-07-05 |
Stable Pharmaceutical Composition For Oral Administration App 20180185359 - MIYAZAKI; Masakazu ;   et al. | 2018-07-05 |
Granular Pharmaceutical Composition App 20180185437 - Nishiura; Mare ;   et al. | 2018-07-05 |
Pyridine derivatives Grant 10,005,762 - Kawaguchi , et al. June 26, 2 | 2018-06-26 |
Methods for treating cancer by inhibiting FGFR3/TACC3 fusion protein Grant 10,004,739 - Suzuki , et al. June 26, 2 | 2018-06-26 |
Cell Culturing Method Using Nucleic Acid-containing Medium App 20180155676 - TAKAGI; Yasuhiro ;   et al. | 2018-06-07 |
Pharmaceutical composition for prevention and/or treatment of urinary incontinence Grant 9,987,279 - Mori , et al. June 5, 2 | 2018-06-05 |
Tetrahydroisoquinoline Derivatives App 20180148458 - Sato; Ippei ;   et al. | 2018-05-31 |
Novel Anti-human Ngf Antibody Fab Fragment App 20180147281 - TANAKA; Hirotsugu ;   et al. | 2018-05-31 |
Production Method of Enzalutamide Crystal Form App 20180148417 - SUZUKI; Yusuke ;   et al. | 2018-05-31 |
Stabilized Pharmaceutical Composition App 20180133325 - TASAKI; Hiroaki ;   et al. | 2018-05-17 |
Pharmaceutical Composition For Oral Administration App 20180116965 - SUDA; Yumiko ;   et al. | 2018-05-03 |
2-acylaminothiazole derivative or salt thereof Grant 9,951,060 - Takahashi , et al. April 24, 2 | 2018-04-24 |
EML4-ALK fusion gene Grant 9,932,589 - Mano , et al. April 3, 2 | 2018-04-03 |
Pharmaceutical composition comprising solifenacin Grant 9,918,970 - Yoshioka , et al. March 20, 2 | 2018-03-20 |
Tetrahydroisoquinoline derivatives Grant 9,914,741 - Sato , et al. March 13, 2 | 2018-03-13 |
Eml4-alk Fusion Gene App 20180066266 - MANO; HIROYUKI ;   et al. | 2018-03-08 |
Anti-human TSLP receptor antibody Grant 9,908,941 - Sato , et al. March 6, 2 | 2018-03-06 |
Anti-human tie-2 antibody Grant 9,902,782 - Kamohara , et al. February 27, 2 | 2018-02-27 |
Pharmaceutical Composition Containing Mirabegron App 20180036288 - TAKAE; SEIJI ;   et al. | 2018-02-08 |
Amide Compound App 20180030030 - OKUDA; Takao ;   et al. | 2018-02-01 |
Bicyclic Pyridine Compound App 20180022755 - KAWAGUCHI; Kenichi ;   et al. | 2018-01-25 |
Pharmaceutical Composition Comprising Bicyclic Nitrogen-containing Aromatic Heterocyclic Amide Compound As Active Ingredient App 20170360780 - NAGASHIMA; Takeyuki ;   et al. | 2017-12-21 |
Pyridine Derivatives App 20170362209 - KAWAGUCHI; Kenichi ;   et al. | 2017-12-21 |
Pharmaceutical Composition Comprising Bicyclic Nitrogen-containing Aromatic Heterocyclic Amide Compound As Active Ingredient App 20170360781 - NAGASHIMA; Takeyuki | 2017-12-21 |
Pharmaceutical Composition Comprising Bicyclic Nitrogen-containing Aromatic Heterocyclic Amide Compound As Active Ingredient App 20170360779 - NAGASHIMA; Takeyuki | 2017-12-21 |
2-aminothiazole derivative or salt thereof Grant 9,844,549 - Takahashi , et al. December 19, 2 | 2017-12-19 |
Novel Genetically Engineered Vaccinia Viruses App 20170340687 - Nakao; Shinsuke ;   et al. | 2017-11-30 |
Therapeutic Agent For Pain App 20170327474 - KISO; Tetsuo ;   et al. | 2017-11-16 |
Anti-human PAI-1 antibody Grant 9,803,024 - Tanaka , et al. October 31, 2 | 2017-10-31 |
Novel Bispecific Antibody Format App 20170306053 - ITO; Yasuhiro ;   et al. | 2017-10-26 |
2-aminothiazole Derivative Or Salt Thereof App 20170290824 - TAKAHASHI; Taisuke ;   et al. | 2017-10-12 |
Pharmaceutical composition for oral administration Grant 9,775,832 - Kojima , et al. October 3, 2 | 2017-10-03 |
Method for treating premature ejaculation and method for controlling premature ejaculation treatment device Grant 9,776,004 - Kimura October 3, 2 | 2017-10-03 |
Novel Pharmaceutical Composition For Prevention And/or Treatment Of Urinary Incontinence App 20170273979 - MORI; Shinobu ;   et al. | 2017-09-28 |
Therapeutic agent for pain Grant 9,765,040 - Kiso , et al. September 19, 2 | 2017-09-19 |
Novel Anti-human Tie-2 Antibody App 20170253669 - Kamohara; Masazumi ;   et al. | 2017-09-07 |
Tetrahydroisoquinoline Derivatives App 20170233402 - SATO; Ippei ;   et al. | 2017-08-17 |
Pharmaceutical Composition For Modified Release App 20170231965 - TAKAISHI; YUUKI ;   et al. | 2017-08-17 |
NOVEL ANTI-HUMAN IgB ANTIBODY App 20170226207 - YAMAJUKU; Daisuke ;   et al. | 2017-08-10 |
Formulations Of Enzalutamide App 20170224624 - Lorenz; Douglas Alan ;   et al. | 2017-08-10 |
Heterocyclic acetamide compound Grant 9,708,307 - Shiraki , et al. July 18, 2 | 2017-07-18 |
2-acylaminothiazole Derivative Or Salt Thereof App 20170197955 - TAKAHASHI; Taisuke ;   et al. | 2017-07-13 |
Pharmaceutical Composition Comprising Pyrazine Carboxamide Compound As Active Ingredient App 20170196859 - KONAGAI; Satoshi ;   et al. | 2017-07-13 |
Anti-human tie-2 antibody Grant 9,683,051 - Kamohara , et al. June 20, 2 | 2017-06-20 |
Tetrahydrooxepinopyridine compound Grant 9,670,219 - Koganemaru , et al. June 6, 2 | 2017-06-06 |
Sulfur-containing bicyclic compound Grant 9,642,852 - Shiraishi , et al. May 9, 2 | 2017-05-09 |
Indole compound Grant 9,637,451 - Matsumoto , et al. May 2, 2 | 2017-05-02 |
Medicinal composition for inhibiting formation and/or enlargement of cerebral aneurysm or shrinking same Grant 9,629,834 - Aoki , et al. April 25, 2 | 2017-04-25 |
Benzazepine compound Grant 9,598,434 - Koshio , et al. March 21, 2 | 2017-03-21 |
Nitrogen-containing bicyclic aromatic heterocyclic compound Grant 9,585,889 - Nakajima , et al. March 7, 2 | 2017-03-07 |
Anti-human CTGF antibody Grant 9,587,015 - Iwasaki , et al. March 7, 2 | 2017-03-07 |
2-acylaminothiazole derivative or salt thereof Grant 9,562,044 - Takahashi , et al. February 7, 2 | 2017-02-07 |
Anti-human IL-23 receptor antibody Grant 9,556,276 - Ohori , et al. January 31, 2 | 2017-01-31 |
Guanidine compound Grant 9,556,160 - Yoshihara , et al. January 31, 2 | 2017-01-31 |
Novel Fgfr3 Fusion App 20160375023A1 - | 2016-12-29 |
Method for producing sulfonyl amidine compound Grant 9,527,818 - Kikuchi , et al. December 27, 2 | 2016-12-27 |
Diamino heterocyclic carboxamide compound Grant 9,487,491 - Shimada , et al. November 8, 2 | 2016-11-08 |
Methods for detecting FGFR3/TACC3 fusion genes Grant 9,481,911 - Suzuki , et al. November 1, 2 | 2016-11-01 |
Nitrogen-containing aromatic heterocyclic compound Grant 9,464,077 - Kameda , et al. October 11, 2 | 2016-10-11 |
Imidazopyridine compounds Grant 9,447,090 - Koga , et al. September 20, 2 | 2016-09-20 |
Bicyclic nitrogen-containing aromatic heterocyclic amide compound Grant 9,428,501 - Ohnuki , et al. August 30, 2 | 2016-08-30 |
Pharmaceutical composition for oral administration Grant 9,408,835 - Takae , et al. August 9, 2 | 2016-08-09 |
Benzothiophene compound Grant 9,399,038 - Ishihara , et al. July 26, 2 | 2016-07-26 |
Indole carboxamide derivative Grant 9,376,449 - Kanayama , et al. June 28, 2 | 2016-06-28 |
Anti-human IL-23 receptor antibody and encoding polynucleotides Grant 9,371,391 - Yonezawa , et al. June 21, 2 | 2016-06-21 |
Method of producing FR901228 Grant 9,371,361 - Ueda , et al. June 21, 2 | 2016-06-21 |
Nitrogen-containing bicyclic aromatic heterocyclic compound Grant 9,328,118 - Nakajima , et al. May 3, 2 | 2016-05-03 |
Anti-human TSLP receptor antibody Grant 9,328,171 - Sato , et al. May 3, 2 | 2016-05-03 |
Tetrahydrobenzothiophene compound Grant 9,284,295 - Hachiya , et al. March 15, 2 | 2016-03-15 |
Imidazopyridine compounds Grant 9,278,968 - Kurosaki , et al. March 8, 2 | 2016-03-08 |
Method for detecting novel FGFR4 mutant Grant 9,267,176 - Futami , et al. February 23, 2 | 2016-02-23 |
Bicyclic heterocyclic compound Grant 9,266,840 - Kawakami , et al. February 23, 2 | 2016-02-23 |
Guanidinobenzoic acid compound Grant 9,199,927 - Fujiyasu , et al. December 1, 2 | 2015-12-01 |
Pharmaceutical composition for oral administration Grant 9,198,904 - Yasuji , et al. December 1, 2 | 2015-12-01 |
Method of treating pain with anti-human NGF antibody Grant 9,127,055 - Kamohara , et al. September 8, 2 | 2015-09-08 |
Benzazepine compound Grant 9,108,977 - Koshio , et al. August 18, 2 | 2015-08-18 |
Pyrazinecarboxamide compound Grant 9,085,540 - Matsuya , et al. July 21, 2 | 2015-07-21 |
Aminoalkyl-substituted N-thienylbenzamide derivative Grant 9,062,032 - Miura , et al. June 23, 2 | 2015-06-23 |
Guanidine compound Grant 9,051,283 - Yoshihara , et al. June 9, 2 | 2015-06-09 |
Oral pharmaceutical compositions in timed-release particle form and fast-disintegrating tablets containing this composition Grant 9,050,249 - Yoshida , et al. June 9, 2 | 2015-06-09 |
Sulfur-containing bicyclic compound Grant 9,051,339 - Shiraishi , et al. June 9, 2 | 2015-06-09 |
Quinoxaline Compound App 20110319385A1 - | 2011-12-29 |
Pharmaceutical Composition Containing Alpha-adrenergic Receptor Antagonist And An Anti-muscarinic Agent And Method Of Improving Lower Urinary Tract Symptoms Associated With Prostatic Hypertrophy App 20100331361A1 - | 2010-12-30 |
NCAGE Code | SAGS7 | ASTELLAS PHARMA INC. |
CAGE Code | SAGS7 | ASTELLAS PHARMA INC. |
SEC | 0001446390 | Astellas Pharma Inc of JAPAN |
SEC | 0001376684 | Astellas Pharma Inc. |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.